Natural Product: NPC608258

Natural Product IDNPC608258
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
LYLDPYNWDVVPIQ-UHFFFAOYSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL124885
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey LYLDPYNWDVVPIQ-UHFFFAOYSA-N
Standard InCHI InChI=1S/C19H18O7/c1-22-13-6-5-10(7-11(13)20)14-8-12(21)17-15(26-14)9-16(23-2)18(24-3)19(17)25-4/h5-9,20H,1-4H3
SMILES COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1O

  Calculated Properties

Physi-Chem Properties

MedChem Properties

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

ADMET: Distribution

ADMET: Metabolism

ADMET: Excretion

ADMET: Toxicity

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22900 Orthosiphon stamineus Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[11374950]
NPO22900 Orthosiphon stamineus Species Lamiaceae Eukaryota n.a. Indonesia n.a. PMID[12467611]
NPO22900 Orthosiphon stamineus Species Lamiaceae Eukaryota aerial parts Bangdung, Indonesia 2000-Aug PMID[12608860]
NPO22900 Orthosiphon stamineus Species Lamiaceae Eukaryota n.a. Taiwan n.a. PMID[15104497]
NPO22900 Orthosiphon stamineus Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO22900 Orthosiphon stamineus Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO22900 Orthosiphon stamineus Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO22900 Orthosiphon stamineus Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO22900 Orthosiphon stamineus Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1603 Individual protein Cytochrome P450 1A1 Homo sapiens Activity = 20.4 % PMID[21482471]
NPT1604 Individual protein Cytochrome P450 1B1 Homo sapiens Ki = 670.0 nM PMID[21482471]
NPT1603 Individual protein Cytochrome P450 1A1 Homo sapiens TIME = 0.1483 hr PMID[21482471]
NPT1603 Individual protein Cytochrome P450 1A1 Homo sapiens Ki = 630.0 nM PMID[21482471]
NPT781 Individual protein Tubulin alpha chain Sus scrofa IC50 > 50000.0 nM PMID[14552774]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT139 Cell line HT-29 Homo sapiens Activity = 95.4 n.a. PMID[15828817]
NPT139 Cell line HT-29 Homo sapiens Activity = 102.1 n.a. PMID[15828817]
NPT2257 Cell line MCF-10A Homo sapiens Activity n.a. n.a. n.a. PMID[21482471]
NPT784 Cell line MDA-MB-468 Homo sapiens Ratio IC50 = 100.0 n.a. PMID[21482471]
NPT111 Cell line K562 Homo sapiens IC50 = 22000.0 nM PMID[14552774]
NPT784 Cell line MDA-MB-468 Homo sapiens Activity n.a. n.a. n.a. PMID[21482471]
NPT30063 Cell line Monocyte Homo sapiens Activity = 0.0 n.a. PMID[8882428]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC608258 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7778 Intermediate Similarity NPC604569
0.7368 Intermediate Similarity NPC606105
0.7358 Intermediate Similarity NPC14958
0.7193 Intermediate Similarity NPC75215
0.7143 Intermediate Similarity NPC50715
0.7091 Intermediate Similarity NPC215932
0.6897 Remote Similarity NPC160951
0.6852 Remote Similarity NPC106461
0.6667 Remote Similarity NPC302408
0.661 Remote Similarity NPC287101
0.6552 Remote Similarity NPC256283
0.6441 Remote Similarity NPC212678
0.6333 Remote Similarity NPC223579
0.6066 Remote Similarity NPC52005
0.6066 Remote Similarity NPC607642
0.5862 Remote Similarity NPC600022
0.5833 Remote Similarity NPC22519
0.5806 Remote Similarity NPC196439
0.5645 Remote Similarity NPC292460
0.5645 Remote Similarity NPC146165
0.5556 Remote Similarity NPC25495
0.5484 Remote Similarity NPC603827
0.5424 Remote Similarity NPC69752
0.541 Remote Similarity NPC138360
0.541 Remote Similarity NPC609062
0.5397 Remote Similarity NPC605582
0.5323 Remote Similarity NPC145379
0.5312 Remote Similarity NPC93376
0.5246 Remote Similarity NPC23955
0.5246 Remote Similarity NPC259058
0.5238 Remote Similarity NPC9609
0.5238 Remote Similarity NPC25270
0.5167 Remote Similarity NPC101294
0.5161 Remote Similarity NPC156222
0.5156 Remote Similarity NPC300943
0.5156 Remote Similarity NPC69394
0.5156 Remote Similarity NPC167815
0.5156 Remote Similarity NPC270620
0.5156 Remote Similarity NPC20830
0.5156 Remote Similarity NPC255350
0.5079 Remote Similarity NPC100887
0.5079 Remote Similarity NPC70853
0.5079 Remote Similarity NPC57030
0.5077 Remote Similarity NPC283600

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC608258 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5156 Remote Similarity NPD2801 Pre-clinical

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data